Clinical Development Progress & Results for QRL-101
Time: 11:30 am
day: Conference Day Two Workshop B
Details:
- QRL-101 impact on hyperexcitability induced neurodegeneration in ALS
- Unveiling preliminary trial results showcasing QRL-101 efficacy and safety data in humans
